. Haplotype analysis for the linkage interval in chromosome 12. The haplotype, highlighted by black square frame, is assumed to carry the inherited disease allele. Recombination was observed between rs2279400 and rs6581040 on patient M16346 at the top, and between rs1174596 and rs187991 on patient M21932 at the bottom. The minimum haplotype segregating with phenotype carrying the disease allele is from rs2279400 to rs187991 (blue square). SLC39A5 is located between rs6581040 and rs774033. Figure S2 . Immunofluorescence showed that SLC39A5 (SLC39A5-GFP: green) was not localized in the membrane of Golgi network (GM130 marker: red). Blue color indicates the nuclei that were stained with DAPI. Figure S3 . Immunofluorescence showed that SLC39A5 (SLC39A5-GFP: green) and the membrane of endoplasmic reticulum (CALRECULALIN marker: red) are co-localization (Merge: yellow). Blue color indicates the nuclei that were stained with DAPI. The missense mutation of SLC39A5 (M304T) did not influence the membrane localization. Figure S4 . A: Immunoblot showed that the protein expression level of SLC39A5 in patients' lymphocyte cell lines (M16346 and M16350) was decreased as compared to the control. B: Real-time qPCR showed that there is no significant difference of mRNA expression level in lymphocyte cell lines between cases and controls. 
